

In December 2005, Bob was diagnosed with non-Hodgkin’s follicular lymphoma and treated using RCHOP chemotherapy. This was followed by stem cell harvest in 2006. A couple of years later, it became evident that he was no longer in remission. After consulting with his haematologist and discussions with family, he joined a double-blind placebo-controlled treatment trial.
At the conclusion of trial in late 2008, Bob was asked if he was interested in becoming a member of the Human Research Ethics Committee. He eventually joined the Gold Coast Health Consumer Advisory Group, which lead him to becoming a health consumer representative on various Haematology and Oncology Committees.
Bob gladly accepted these requests, and is now currently a member of the Human Research Ethics Committee, CBD Quality and Safety Committee, and CBD Consumer Engagement Committee.